Ingestible Sensors Market Worth $1.99 Billion by 2024 | CAGR 19.1%: Grand View Research, Inc.
SAN FRANCISCO, September 24, 2018 /PRNewswire/ --
The global ingestible sensors market size is expected to reach USD 1.99 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to register a strong CAGR of 19.1% over the forecast period. Growing need for medical adherence and real-time monitoring of health along with rising prevalence of chronic diseases are some of the factors driving the market growth. Patient compliance is another key factor boosting the usage of ingestible sensors.
Simple procedure, user convenience, and minimal side effects are the factors leading to increased medical adherence by patients of all age groups, thus, driving the market growth. Increasing cases of chronic diseases, such as diabetes, hypertension, and cancer have also led to the market expansion. According to the International Diabetes Federation (IDF), around 642 million people across the world are projected to have diabetes by 2040.
In addition, growing geriatric population is also leading to numerous health issues, which is further raising the incidences of such chronic diseases. With technological advancements, ingestible sensors are growing rapidly in the field of digital medicine. Thus, it is anticipated to grow further in applications like customized drug delivery. However, costly raw materials and techniques for the development and design of this product may impede the market growth.
Browse full research report with TOC on "Ingestible Sensors Market Size, Share & Trends Analysis Report By Vertical (Sports, Medical), By Component (Sensors, Software), By Sensor Type (Temperature, Pressure, Image Sensors), And Segment Forecasts, 2018 - 2024" at:https://www.grandviewresearch.com/industry-analysis/ingestible-sensors-market
Further Key Findings From the Report Suggest:
In 2016, temperature sensors led the market owing to their benefits in diagnosing and treating heat-related illness, particularly among athletes
Image sensors are projected to show a significant growth over the forecast period due to their accuracy and clear images for the diagnosis of critical diseases
Sensors held the largest market share in 2016 amongst the component segment due to the advanced and expensive technology used in these devices
Medical segment accounted for the largest market share in 2016 owing to huge scope of application for ingestible sensors in drug delivery and patient monitoring
North America held the largest market revenue in 2016 due to high awareness levels regarding the availability of advanced technologies
Asia Pacific is anticipated to register a significant CAGR over the forecast period on account of increasing geriatric population and prevalence of chronic diseases, especially in the developing countries
Some of the key companies in the market are Proteus Digital Healthcare; CapsoVision Inc.; Given Imaging Ltd; Olympus Corporation; Medimetrics Inc.; HQ Inc.; MC10 Inc.; and Microchips Biotech Inc.
Browse related reports by Grand View Research:
Nuclear Medicine Equipment Market - The global nuclear medicine equipment market size was valued at USD 1.7 billion in 2015 and is expected to witness an attractive growth over the forecast period.
Weight Management Market - The global weight management market size was valued at USD 214.7 billion in 2016 and is expected to grow at a CAGR of 8.3% over the forecast period.
Surgical Sealants And Adhesives Market - The global surgical sealants and adhesives market size was valued at USD 1.8 billion in 2015 and is projected to grow at a CAGR of 9.7% over the forecast period.
Clinical Chemistry Analyzers Market - The global clinical chemistry analyzers market accounted for USD 9.9 billion in 2016 and is expected to grow at a CAGR of 5.5% during the forecast period.
Grand View Research has segmented the global ingestible sensors market on the basis of component, sensor type, vertical, and region:
Ingestible SensorsComponent Outlook (Revenue, USD Million, 2014 - 2024)
Sensors
Wearable Patch/Data Recorder
Software
Ingestible SensorsType Outlook (Revenue, USD Million, 2013 - 2024)
Temperature Sensor
Pressure Sensor
pH Sensor
Image Sensor
Ingestible SensorsVertical Outlook (Revenue, USD Million, 2013 - 2024)
Medical
Sports and Fitness
Others
Ingestible SensorsRegional Outlook (Revenue, USD Million, 2013 - 2024)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
India
Latin America
Brazil
Mexico
Middle East and Africa (MEA)
South Africa
Saudi Arabia
Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...